questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Ureohydrolases
Ureohydrolases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Déficience enzymatique
Urée
Ammoniac
Tests enzymatiques
Biochimie clinique
Ureohydrolases
Symptômes neurologiques
Fatigue
Confusion
Tests génétiques
Mutations
Déficience enzymatique
Antécédents médicaux
Troubles métaboliques
Hérédité
Symptômes
5
Nausées
Vomissements
Troubles de la conscience
Hyperammoniémie
Céphalées
Convulsions
Nourrissons
Enfants
Symptômes
Irritabilité
Léthargie
Troubles de l'alimentation
Conditions médicales
Symptômes
Déficience enzymatique
Prévention
5
Prévention
Dépistage
Risques
Conseils diététiques
Accumulation d'urée
Prévention
Dépistage néonatal
Troubles métaboliques
Prévention
Antécédents familiaux
Suivi médical
Prévention
Vaccinations
Prévention
Troubles
Traitements
5
Restriction protéique
Suppléments
Arginine
Médicaments
Ammoniac
Gestion des symptômes
Dialyse
Ammoniac
Traitement
Thérapie nutritionnelle
Niveaux d'urée
Gestion
Thérapie génique
Traitements expérimentaux
Recherche
Complications
5
Hyperammoniémie
Lésions cérébrales
Complications
Troubles du comportement
Accumulation d'ammoniac
Complications
Qualité de vie
Complications
Soins constants
Complications
Traitement
Réversibilité
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Maladies métaboliques
Alimentation
Protéines
Facteurs de risque
Infections
Symptômes
Ammoniac
Facteurs environnementaux
Pollution
Métabolisme
Médicaments
Métabolisme
Urée
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ureohydrolases : Questions médicales les plus fréquentes",
"headline": "Ureohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ureohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ureohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Arginase",
"alternateName": "Arginase",
"url": "https://questionsmedicales.fr/mesh/D001119",
"about": {
"@type": "MedicalCondition",
"name": "Arginase",
"code": {
"@type": "MedicalCode",
"code": "D001119",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.913.292"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ureohydrolases",
"alternateName": "Ureohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D014512",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "M Sinn",
"url": "https://questionsmedicales.fr/author/M%20Sinn",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de."
}
},
{
"@type": "Person",
"name": "L Riede",
"url": "https://questionsmedicales.fr/author/L%20Riede",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "J R Fleming",
"url": "https://questionsmedicales.fr/author/J%20R%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "D Funck",
"url": "https://questionsmedicales.fr/author/D%20Funck",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "H Lutz",
"url": "https://questionsmedicales.fr/author/H%20Lutz",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Engaging Early-Career Scientists in Global Policy-Making.",
"datePublished": "2023-06-28",
"url": "https://questionsmedicales.fr/article/37377145",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/anie.202217841"
}
},
{
"@type": "ScholarlyArticle",
"name": "Decision making under deep uncertainty for pandemic policy planning.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37156082",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.healthpol.2023.104831"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Modelling Framework for Evidence-Based Public Health Policy Making.",
"datePublished": "2022-05-05",
"url": "https://questionsmedicales.fr/article/35025752",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/JBHI.2022.3142503"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evidence-Informed Oral Health Policy Making: Opportunities and Challenges.",
"datePublished": "2023-08-10",
"url": "https://questionsmedicales.fr/article/37585875",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00220345231187828"
}
},
{
"@type": "ScholarlyArticle",
"name": "E-participation in policy-making for health: a scoping review protocol.",
"datePublished": "2024-09-16",
"url": "https://questionsmedicales.fr/article/39284702",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2023-080538"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ureohydrolases",
"item": "https://questionsmedicales.fr/mesh/D014512"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ureohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ureohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ureohydrolases",
"description": "Comment diagnostiquer une déficience en ureohydrolases ?\nQuels tests sont utilisés pour évaluer l'activité des ureohydrolases ?\nQuels symptômes indiquent un problème avec les ureohydrolases ?\nLes tests génétiques sont-ils utiles pour les ureohydrolases ?\nComment l'historique médical aide-t-il au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Policy+Making#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ureohydrolases",
"description": "Quels sont les symptômes d'une accumulation d'urée ?\nComment se manifeste une hyperammoniémie ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont associés à une déficience en ureohydrolases ?\nPeut-on avoir des symptômes sans déficience enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Policy+Making#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ureohydrolases",
"description": "Peut-on prévenir les troubles liés aux ureohydrolases ?\nLes conseils diététiques peuvent-ils prévenir ces troubles ?\nLe dépistage néonatal est-il recommandé ?\nLes antécédents familiaux influencent-ils la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Policy+Making#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ureohydrolases",
"description": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLa dialyse est-elle une option de traitement ?\nLes thérapies nutritionnelles sont-elles efficaces ?\nY a-t-il des traitements expérimentaux pour ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Policy+Making#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ureohydrolases",
"description": "Quelles complications peuvent survenir avec une hyperammoniémie ?\nLes troubles du comportement sont-ils une complication ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Policy+Making#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ureohydrolases",
"description": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?\nL'alimentation joue-t-elle un rôle dans les facteurs de risque ?\nLes infections peuvent-elles aggraver les troubles ?\nLes facteurs environnementaux influencent-ils ces troubles ?\nLes médicaments peuvent-ils être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Policy+Making#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en ureohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires mesurant les niveaux d'urée et d'ammoniac sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des ureohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques et des analyses biochimiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les ureohydrolases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la confusion, la fatigue et des troubles neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les ureohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations génétiques liées à des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Comment l'historique médical aide-t-il au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical peut révéler des antécédents familiaux de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une accumulation d'urée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une hyperammoniémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des troubles neurologiques, des céphalées et des convulsions."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus graves chez les nourrissons et les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience en ureohydrolases ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'irritabilité, la léthargie et des troubles de l'alimentation peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans déficience enzymatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres conditions médicales peuvent provoquer des symptômes similaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux ureohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage précoce peut aider à gérer les risques."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils prévenir ces troubles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils diététiques peuvent réduire le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Le dépistage néonatal est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage néonatal peut identifier les troubles métaboliques précocement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles peuvent justifier un suivi médical accru."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne préviennent pas directement les troubles liés aux ureohydrolases."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est une restriction protéique et des suppléments d'arginine."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour réduire les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle une option de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dialyse peut être utilisée pour éliminer l'excès d'ammoniac dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les thérapies nutritionnelles sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une thérapie nutritionnelle adaptée peut aider à gérer les niveaux d'urée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour ces troubles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une hyperammoniémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves incluent des lésions cérébrales et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent survenir en raison de l'accumulation d'ammoniac."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie et nécessiter des soins constants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir à tout âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent survenir à tout âge, mais sont plus fréquentes chez les jeunes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et des régimes inappropriés."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en protéines peut augmenter le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les troubles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils ces troubles ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter le métabolisme."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec le métabolisme de l'urée et des enzymes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/02/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany. joerg.hartig@uni-konstanz.de.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany. joerg.hartig@uni-konstanz.de.
Publications dans "Ureohydrolases" :
Pressing global challenges, such as climate change, the COVID-19 pandemic, or antibiotic resistance, require coordinated international responses guided by evidence-informed decisions. For this purpose...
Policymakers around the world were generally unprepared for the global COVID-19 pandemic. As a result, the virus has led to millions of cases and hundreds of thousands of deaths. Theoretically, the nu...
It is widely recognised that the process of public health policy making (i.e., the analysis, action plan design, execution, monitoring and evaluation of public health policies) should be evidenced bas...
Despite a clear need for improvement in oral health systems, progress in oral health systems transformation has been slow. Substantial gaps persist in leveraging evidence and stakeholder values for co...
For the general public, e-participation represents a potential solution to the challenges associated with in-person participation in health policy-making processes. By fostering democratic engagement,...
We will employ the Population, Concept and Context framework developed by Arksey and O'Malley (2005). Our population of interest will consist of participants involved in policy-making for health, incl...
The National Institute of Health Research of the Islamic Republic of Iran's ethics committee has approved this review study. Our findings will be disseminated through peer-reviewed publications, confe...
Public health policies are crucial for the well-being of the general population; however, the health systems of developed countries still do not include oral health in its system. Thus, it is necessar...
Evidence-informed policy-making (EIPM) requires a set of individual and organizational capacities, linked with background factors and needs. The identification of essential knowledge, skills and attit...
To identify elements of competency (knowledge, skills and attitudes) for EIPM, according to different professional profiles (researcher, health professional, decision-maker and citizen)....
Rapid umbrella review. A structured search was conducted and later updated in two comprehensive repositories (BVSalud and PubMed). Review studies with distinctive designs were included, published from...
Ten reviews were included. A total of 37 elements of competency were identified, eight were categorized as knowledge, 19 as skills and 10 as attitudes. These elements were aggregated into four compete...
This study is innovative because it aggregates different profiles of competency from a practical perspective, favouring the application of its results in different contexts to support EIPM. Methodolog...
CONCLUSIONS AND IMPLICATIONS OF THE FINDINGS: EIPM requires the development of individual and organizational capacities. This rapid review contributes to the discussion on the institutionalization of ...
Nurses can play a valuable role in not only the implementation but development of general and health policies. However, evidence indicates limited involvement of nurses in politics and general health ...
Strategies are required to increase nurses' participation and engagement in policymaking. However, no studies explored the perspective of nurse leaders in policy making roles and how to improve nurses...
To explore strategies to enhance nurses' involvement in policy making from the perspective of nurse leaders....
A qualitative descriptive study was conducted. Semistructured interviews were conducted with a purposive sample of 11 nurse leaders with at least one year of experience in policy making. Data were ana...
Five themes were generated: strategically revisit and implement educational approaches, becoming transformative leaders, improving social image of nurses, developing triadic partnerships, and empoweri...
Nurses' involvement in policymaking can be enhanced by implementing grassroots-level educational strategies, managerial-level empowerment efforts, and social mechanisms focused on improving the social...
Self and professional role empowerment through education, increasing awareness, and improving the social image of nursing can boost nurses' involvement in policymaking....
Nurse leaders, national and global nursing associations, and nursing regulatory bodies should collaborate with associations of nursing colleges to design nurse policymaking competencies framework and ...
Complexity theory and systems-thinking are increasingly popular in physical activity (PA) research and policy discourse. The impact of this perspective shift, across many sectors, may be underwhelming...
We adopted a complex realist position. Ten semi-structured interviews were conducted with national-level policy-makers from United Kingdom government settings (five civil servants, three politicians, ...
Three overarching themes were constructed to reflect policy-makers' uncertainty about complexity and the application of such perspectives to this policy space, their sense that PA was an unexceptionab...
This research highlighted the importance of extending complexity theory and systems-thinking. While emphasizing the prevalence of these ideas across the PA sector, there is uncertainty as to their mea...
Evidence-informed policy-making benefitted from much-needed attention and resources during the COVID-19 pandemic (1). As a result, 3 key movements and innovations are now making it possible to provide...